XML 62 R16.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

STOCK-BASED COMPENSATION | 9 Months Ended
--- | ---
Dec. 31, 2019
Share-based Payment Arrangement [Abstract] |
STOCK-BASED COMPENSATION | STOCK-BASED COMPENSATION The following tables summarize information pertaining to the stock-based compensation expense from stock options and stock awards (in thousands, except weighted-average grant-date fair value and recognition period):
|  | Three Months Ended December 31, |  | Nine Months Ended December 31,
|  | 2019 |  | 2018 |  | 2019 |  | 2018
Cost of service revenue |  | $ | 2,226 |  |  | $ | 1,562 |  |  | $ | 5,896 |  |  | $ | 3,967 |
Research and development |  | 5,535 |  |  | 3,570 |  |  | 13,616 |  |  | 8,587 |
Sales and marketing |  | 5,197 |  |  | 3,798 |  |  | 14,458 |  |  | 8,402 |
General and administrative |  | 6,359 |  |  | 3,605 |  |  | 16,335 |  |  | 10,619 |
Total |  | $ | 19,317 |  |  | $ | 12,535 |  |  | $ | 50,305 |  |  | $ | 31,575 |
|  | Nine Months Ended December 31,
|  | 2019 |  | 2018
Stock options outstanding at the beginning of the period: |  | 3,114 |  |  | 3,998 |
Options granted |  | — |  |  | 222 |
Options exercised |  | (391 | ) |  | (641 | )
Options canceled and forfeited |  | (55 | ) |  | (192 | )
Options outstanding at the end of the period: |  | 2,668 |  |  | 3,387 |
Weighted-average fair value of grants during the period |  | $ | — |  |  | $ | 8.27 |
Total intrinsic value of options exercised during the period |  | $ | 4,844 |  |  | $ | 9,148 |
Weighted-average remaining recognition period at period-end (in years) |  | 2.16 |  |  | 2.53 |
Stock awards outstanding at the beginning of the period: |  | 7,820 |  |  | 5,939 |
Stock awards granted |  | 5,886 |  |  | 4,993 |
Stock awards vested |  | (2,860 | ) |  | (2,123 | )
Stock awards canceled and forfeited |  | (1,056 | ) |  | (700 | )
Stock awards outstanding at the end of the period: |  | 9,790 |  |  | 8,109 |
Weighted-average fair value of grants during the period |  | $ | 22.35 |  |  | $ | 20.05 |
Weighted-average remaining recognition period at period-end (in years) |  | 2.13 |  |  | 2.40 |
Total unrecognized compensation expense at period-end |  | $ | 143,593 |  |  | $ | 112,970 |
Stock Repurchases In May 2017, the Company's board of directors authorized the Company to purchase up to $25.0 million of its common stock from time to time (the "2017 Repurchase Plan"). The 2017 Repurchase Plan expires when the maximum purchase amount is reached, or upon the earlier revocation or termination by the board of directors. The remaining amount available under the 2017 Repurchase Plan at December 31, 2019 was approximately $7.1 million. There were no stock repurchases under the 2017 Repurchase Plan during the three and nine months ended December 31, 2019.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration